爆发
医学
流感季节
病毒学
甲型流感病毒
急诊医学
病毒
流感疫苗
作者
Noah Kojima,Annabelle de St. Maurice,Earl J Erezo,Erika Yanez,Elizabeth Traub,Allison Joyce,Amy Marutani,Nicole M. Green,Sharon Balter,Sheree R Poitier,Jan King
摘要
Baloxavir marboxil is approved for influenza treatment and post-exposure prophylaxis (PEP). There are limited real-world examples of its use in influenza outbreaks. Here, we describe the use of baloxavir marboxil as PEP to halt an influenza outbreak among a college sports team during the 2024-2025 influenza season.
科研通智能强力驱动
Strongly Powered by AbleSci AI